Hepatitis B Virus-related Membranous Nephropathy with Crescentic Formation in an Inactive Carrier of Positive Hepatitis B Surface Antigen with Undetectable DNA under Anti-viral Treatment

被引:0
|
作者
Kounoue, Noriyuki [1 ,2 ]
Oguchi, Hideyo [1 ]
Mikami, Tetuo [3 ]
Yamaguchi, Yutaka [4 ]
Hashiguchi, Akinori [5 ]
Nagai, Hidenari [6 ]
Watanabe, Kaori [1 ]
Furukawa, Satoshi [1 ]
Hisamatsu, Kana [1 ]
Sakai, Ken [1 ]
机构
[1] Toho Univ, Fac Med, Dept Nephrol, Tokyo, Japan
[2] Toho Univ, Grad Sch Med, Dept Nephrol, Tokyo, Japan
[3] Toho Univ, Fac Med, Dept Pathol, Tokyo, Japan
[4] Yamaguchis Pathol Lab, Chiba, Japan
[5] Keio Univ, Dept Pathol, Sch Med, Keio, Japan
[6] Toho Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Fac Med, Tokyo, Japan
关键词
membranous nephropathy; hepatitis B virus; hepatitis B virus-related membranous nephropathy; inactive carrier; case report; GLOMERULONEPHRITIS; RECEPTOR;
D O I
10.2169/internalmedicine.1515-22
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A man who was an inactive hepatitis B virus (HBV) carrier with positive hepatitis B surface antigen (HBs antigen) and undetectable HBV-DNA under anti-viral treatment developed nephrotic syndrome at 52 years old, and a renal biopsy revealed advanced membranous nephropathy (MN) with focal cellular crescents, inter-stitial hemorrhaging, and peritubular capillaritis. Immunofluorescence studies demonstrated granular IgG deposition and HBs antigen-positivity along the capillaries. Glomeruli were negative for phospholipase A2 re-ceptor 1. There were no clinical findings of systemic vasculitis. We considered MN combined with small-vessel vasculitis due to HBV infection. These results suggest that HBV-related kidney disease should be con -sidered even in patients with an inactive HBV carrier status under treatment.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 50 条
  • [31] Correlation of Quantitative Hepatitis B Surface Antigen (qHBsAg) with Hepatitis B Virus (HBV) DNA Levels as an Indicator of Viral Clearance
    Nixon, Mary Lape
    Kagan, Ron M.
    Schwab, Dale A.
    Pesano, Rick
    Baumann, Russell
    Batterman, Hollis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S512 - S512
  • [32] DETECTABLE HBV DNA AT TREATMENT BASELINE PREDICTED HEPATITIS B VIRUS REACTIVATION IN INFLAMMATORY ARTHRITIS PATIENTS WITH NEGATIVE HEPATITIS B SURFCE ANTIGEN BUT POSITIVE ANTI-HEPATITIS B CORE ANTIGEN
    Ho, Grace Chup-Hei
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1638 - 1639
  • [33] ANTIVIRAL THERAPY DOES NOT IMPROVE OUTCOMES OF PATIENTS WITH HEPATITIS B VIRUS-RELATED DECOMPENSATED CIRRHOSIS AND UNDETECTABLE DNA
    Lee, Han Ah
    Kim, Hwi Young
    Kim, Seung Up
    Seo, Yeon Seok
    HEPATOLOGY, 2022, 76 : S271 - S271
  • [34] Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels
    Chang, Jong-In
    Sinn, Dong Hyun
    Cho, Hyun
    Kim, Seonwoo
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (09) : 4565 - 4573
  • [35] IMMUNOPROPHYLAXIS OF INFECTION WITH HEPATITIS-B VIRUS IN INFANTS BORN TO HEPATITIS-B SURFACE ANTIGEN-POSITIVE CARRIER MOTHERS
    LO, KJ
    TSAI, YT
    LEE, SD
    WU, TC
    WANG, JY
    CHEN, GH
    YEH, CL
    CHIANG, BN
    YEH, SH
    GOUDEAU, A
    COURSAGET, P
    TONG, MJ
    JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (04): : 817 - 825
  • [36] Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience
    O'Brien, Sheila F.
    Fearon, Margaret A.
    Yi, Qi-Long
    Fan, Wenli
    Scalia, Vito
    Muntz, Irene R.
    Vamvakas, Eleftherios C.
    TRANSFUSION, 2007, 47 (10) : 1809 - 1815
  • [37] Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa
    Shimakawa, Yusuke
    Ndow, Gibril
    Njie, Ramou
    Njai, Harr Freeya
    Takahashi, Kazuaki
    Akbar, Sheikh Mohammad Fazle
    Cohen, Damien
    Nayagam, Shevanthi
    Jeng, Adam
    Ceesay, Arnie
    Sanneh, Bakary
    Baldeh, Ignatius
    Imaizumi, Masayasu
    Moriyama, Kazushige
    Aoyagi, Katsumi
    D'Alessandro, Umberto
    Mishiro, Shunji
    Chemin, Isabelle
    Mendy, Maimuna
    Thursz, Mark R.
    Lemoine, Maud
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1442 - 1452
  • [38] Letter: pre- and post-operative anti-viral therapy is important for patients with hepatitis B virus-related hepatocellular carcinoma
    Zhong, J. -H.
    Xiang, B. -D.
    Li, L. -Q.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) : 789 - 790
  • [39] The impact of early hepatitis B virus viral suppression on treatment response in entecavir-treated hepatitis B e antigen-positive chronic hepatitis B
    Huang, Yi-Jie
    Chang, Chi-Sen
    Yeh, Hong-Zen
    Yang, Sheng-Shun
    Chang, Chung-Hsin
    ADVANCES IN DIGESTIVE MEDICINE, 2024, 11 (01) : 8 - 15
  • [40] Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy
    Xiong, Q. -F.
    Zhong, Y. -D.
    Hu, Z. -L.
    Yang, Y. -F.
    ACTA CLINICA BELGICA, 2015, 70 (03) : 223 - 225